Scholars Central

EditorialPublished 31 Mar 2021

Bioequivalence, Interchangeability and substitution

Authors: David Sebastian

Journal of Bioequivalence & Bioavailability

Volume 13 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Makers should lead studies to decide if their form is bioequivalent to the first medication—that will be, that the conventional rendition delivers its dynamic fixing (the medication) into the circulation system at for all intents and purposes a similar speed and in basically similar sums as the first medication.Since the dynamic fixing in the nonexclusive medication has effectively been appeared in testing of the brand-name medication to be protected and powerful, bioequivalence concentrates just need to show that the conventional adaptation delivers practically similar degrees of medication in the blood over the long run and subsequently require just a moderately modest number (24 to 36) of solid volunteers.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “David Sebastian”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels